Mohammadzadeh Alireza, Jafari Naser, Babapoursaatlou Behzad, Doustkami Hossein, Hosseinian Adallat, Hasanpour Mohammad
Department of Cardiothoracic, Imam Khomeini Hospital, Ardabil 56197, Iran.
ISRN Cardiol. 2012;2012:204624. doi: 10.5402/2012/204624. Epub 2012 Aug 2.
The present study has investigated the effectiveness of staged-preconditioning, in both remote and target organs. After IP the myocardial release of the biochemical markers including, creatine phosphokinase (CPK), cardiac creatine kinase (CK-MB), cardiac troponin T (cTnT) and lactate dehydrogenase (LDH) were evaluated in patients who underwent CABG, with and without staged-preconditioning. Sixty-one patients entered the study; there were 32 patients in the staged-preconditioning group and 29 patients in the control group. All patients underwent on-pump CABG using cardiopulmonary bypass (CPB) techniques. In the staged-preconditioning group, patients underwent two stages of IP on remote (upper limb) and target organs. Each stage of preconditioning was carried out by 3 cycles of ischemia and then reperfusion. Serum levels of biochemical markers were immediately measured postoperatively at 24, 48 and 72 h. Serum CK-MB, CPK and LDH levels were significantly lower in the staged-preconditioning group than in the control group. The CK-MB release in the staged-preconditioning patients reduced by 51% in comparison with controls over 72 h after CABG. These results suggest that myocardial injury was attenuated by the effect of three rounds of both remote and target organ IP.
本研究调查了分期预处理在远隔器官和靶器官中的有效性。在接受冠状动脉旁路移植术(CABG)的患者中,无论有无分期预处理,经腹腔注射后,评估包括肌酸磷酸激酶(CPK)、心肌肌酸激酶(CK-MB)、心肌肌钙蛋白T(cTnT)和乳酸脱氢酶(LDH)在内的生化标志物的心肌释放情况。61例患者进入研究;分期预处理组有32例患者,对照组有29例患者。所有患者均采用体外循环(CPB)技术进行心脏不停跳CABG。在分期预处理组中,患者在远隔器官(上肢)和靶器官进行了两个阶段的腹腔注射。预处理的每个阶段均通过3个缺血再灌注周期进行。术后24、48和72小时立即测量生化标志物的血清水平。分期预处理组的血清CK-MB、CPK和LDH水平显著低于对照组。与对照组相比,分期预处理患者在CABG后72小时内CK-MB的释放减少了51%。这些结果表明,三轮远隔器官和靶器官腹腔注射的作用减轻了心肌损伤。